Quotables
"The horse is here to stay, the automobile is only a novelty - fad."
President of Michigan Savings Bank ; 1903
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20100222435 | MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medic... | 09/02/2010 |
| 20100178353 | QUICK DISSOLVE COMPOSITIONS AND TABLETS BASED THEREON The invention provides a composition useful for making oral dosage forms capable of dissolving in the mouth in less than 40 seconds without the need for a conventional super disintegrant and having a friability of less than 1%; wherein the composition includes liquiflas... | 07/15/2010 |
| 20100104639 | BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.... | 04/29/2010 |
| 20100068270 | BUPROPION HYDROBROMIDE POLYMORPHS Polymorphous and amorphous forms of bupropion hydrobromide are described.... | 03/18/2010 |
| 20090269402 | MODIFIED RELEASE COMPOSITION OF AT LEAST ONE FORM OF VENLAFAXINE The present invention relates to a modified release composition of at least one form of venlafaxine, which is a delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine selected from the group consisting of ven... | 10/29/2009 |
| 20090142378 | CONTROLLED RELEASE DOSAGE FORMS The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functi... | 06/04/2009 |
| 20090118256 | CHRONOTHERAPEUTIC DILTIAZEM FORMULATIONS AND THE ADMINISTRATION THEREOF A method of treating or preventing myocardial ischemia in a patient in need thereof comprising administration of a controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for eve... | 05/07/2009 |
| 20090004281 | MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM The present invention relates to a multiparticulate osmotic delivery system. The system is a modified release composition suitable for oral administration. The composition includes a core that includes at least one drug in combination with at least one pharmaceutically ... | 01/01/2009 |
| 20080274177 | CONTROLLED RELEASE DOSAGE FORMS The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functi... | 11/06/2008 |
| 20080175873 | MODIFIED RELEASE COMPOSITION OF AT LEAST ONE FORM OF VENLAFAXINE The present invention relates to a modified release composition of at least one form of venlafaxine, which is an enhanced absorption delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine, less than 10% of a ... | 07/24/2008 |
| 20080138411 | Modified Release Formulations Of Selective Serotonin Re-Uptake Inhibitors The present invention relates to modified release pharmaceutical compositions for oral administration and more particularly to modified release pharmaceutical compositions of a form of at least one selective serotonin re-uptake inhibitor selected from the group consisti... | 06/12/2008 |
| 20080138404 | EXTENDED RELEASE FORMULATIONS OF CARVEDILOL An improved controlled release dosage form for once-daily administration of carvedilol is described. The controlled release dosage form comprises a therapeutically effective amount of carvedilol and/or a pharmaceutically acceptable salt thereof; one or more hydrophilic ... | 06/12/2008 |
| 20080069888 | MODIFIED RELEASE FORMULATIONS OF AT LEAST ONE FORM OF TRAMADOL The present invention relates to a modified release composition of at least one form of tramadol which is a delayed and extended release composition for oral administration suitable for once daily dosing. That composition comprises a core comprising at least one form of... | 03/20/2008 |
| 20070276047 | MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medic... | 11/29/2007 |
